Matthew Cooper is a seasoned leader in the life sciences sector, currently serving as the CEO and Founder of Enumera Molecular, a company focused on innovative detection platforms for biomolecules via liquid biopsy. Matthew has extensive experience as a Board Member at Avails Medical, guiding digital pathogen detection solutions, and at NeoSeq, which specializes in advanced healthcare diagnostics. As a General Manager and Chief Scientific Officer at Progenity, Matthew oversaw diagnostics, R&D, and corporate strategy. Additional roles include Adviser and Mentor at StartX and UCSF, contributing to entrepreneurial initiatives in life sciences. Matthew's educational background includes an MBA in Finance from Columbia Business School and a Ph.D. in Toxicology from the University of Kentucky College of Medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices